TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RVTY

Revvity Inc.

Healthcare · Diagnostics & Research

151.10$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Revvity Inc. (RVTY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 12,168 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RVTY
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
823 832 1,139 1,715 2,188 2,970 2,836 2,608 2,576 2,693 2,510 2,949 2,932 3,059 3,209 3,856 3,902 3,947 4,128 4,166 4,277 6,091 5,976 6,539 7,960 15,001 14,130 13,565 12,392 12,168
455 488 532 815 926 943 991 766 748 999 745 843 831 884 1,085 883 972 1,045 1,069 1,033 1,190 1,200 1,235 1,374 2,239 2,441 3,289 3,001 2,350 2,240
48 58 96 127 126 138 131 191 198 502 191 203 179 180 420 142 171 173 175 238 359 202 163 192 402 603 454 913 1,163 920
48 58 96 127 126 138 131 191 198 502 191 203 179 180 420 142 171 173 175 238 359 202 163 192 402 603 454 1,603 1,163 920
223 244 170 346 293 319 305 288 258 251 268 338 331 320 357 410 457 467 471 415 426 552 633 725 1,155 708 613 633 632 745
120 113 124 202 191 245 205 189 170 163 183 202 200 179 207 241 248 261 285 259 247 352 338 357 515 426 405 428 368 379
– – – – – – – – – – – – – – – – – – – – – – – 485 576 650 671 – – –
– – – – – – – – – 1,026 1,118 1,356 1,396 1,419 1,505 2,094 2,123 2,143 2,284 2,237 2,248 3,002 2,953 3,111 3,447 6,627 6,482 6,534 6,464 6,613
110 79 318 592 887 1,530 1,440 1,460 1,435 375 404 479 452 443 424 662 530 460 490 486 420 1,347 1,200 1,283 1,366 3,822 3,377 3,022 2,641 2,347
458 504 739 1,164 1,460 1,606 1,584 1,259 1,115 1,043 933 1,374 1,364 1,430 1,284 2,013 1,962 1,952 2,085 2,056 2,123 3,588 3,391 3,725 4,225 7,859 6,747 5,692 4,726 4,918
260 286 485 853 646 755 698 452 446 495 477 548 516 497 515 599 581 603 597 561 603 951 772 763 1,652 1,214 1,544 1,450 653 1,331
22 46 158 382 183 126 191 5.2 9.7 1.1 1.2 0.6 0.0 0.1 2.3 -138 1.8 2.6 1.1 1.1 1.2 217 16 47 421 34 502 755 24 589
76 73 73 153 118 129 146 154 127 147 153 186 171 134 161 173 169 167 174 141 168 222 221 236 327 325 273 204 167 185
– – – – – – – – – – – – – – – – – – – – – – – 2,064 1,610 4,980 3,923 3,178 3,150 2,631
365 328 400 551 728 1,364 1,252 1,349 1,460 1,651 1,578 1,575 1,568 1,629 1,925 1,842 1,940 1,994 2,042 2,110 2,154 2,503 2,585 2,814 3,735 7,141 7,383 7,873 7,667 7,250
532 540 624 762 836 842 655 673 733 965 1,040 1,142 1,236 1,289 1,535 1,511 1,549 1,684 1,811 1,991 2,119 2,381 2,602 2,812 3,507 4,417 4,951 5,609 5,845 6,054
95 91 92 91 102 108 126 129 130 131 126 121 119 117 118 114 115 114 114 113 110 111 112 112 112 117 126 125 123 113

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?